comparemela.com
Home
Live Updates
Methylation Sciences Inc - Breaking News
Pages:
Latest Breaking News On - Methylation sciences inc - Page 1 : comparemela.com
XORTX Announces Appointment of Chief Technology Officer
CALGARY, Alberta, Jan. 20, 2022 (GLOBE NEWSWIRE) XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a.
Nick rigopulos
Allen davidoff
University of alberta
Therapeutics inc
Methylation sciences inc
David macdonald
Chief technology officer
Active pass
Autosomal dominant polycystic kidney disease
Tsx venture exchange xrtx
Ortx therapeutics inc
XORTX Announces Appointment of Chief Technology Officer
20.01.2022 - CALGARY, Alberta, Jan. 20, 2022 (GLOBE NEWSWIRE) - XORTX Therapeutics Inc. ( XORTX or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a pharmaceutical therapeutics company focused on developing innovative therapies to treat .
Nick rigopulos
Allen davidoff
University of alberta
Therapeutics inc
Methylation sciences inc
Active pass
Autosomal dominant polycystic kidney disease
XORTX Announces Appointment of Chief Technology Officer
XORTX Announces Appointment of Chief Technology Officer - read this article along with other careers information, tips and advice on BioSpace
Nick rigopulos
Allen davidoff
University of alberta
Therapeutics inc
Methylation sciences inc
Venture exchange
David macdonald
Chief technology officer
Active pass
Autosomal dominant polycystic kidney disease
Ortx announces appointment of chief technology officer
vimarsana © 2020. All Rights Reserved.